Composition, form of production and packaging
? Drops for ingestion in the form of a transparent, from light yellow to yellow-brown solution with a characteristic acidic odor.
100 ml
free germinal substrate of metabolic products Escherichia coli DSM 4087 24.9481 g
free germinal substrate of metabolic products Streptococcus faecalis DSM 4086 12.4741 g
free germinal substrate of metabolic products Lactobacillus acidophilus DSM 4149 12.4741 g
germ-free aqueous substrate of metabolic products Lactobacillus helveticus DSM 4183 49.896 g
Excipients: sodium phosphate heptahydrate, potassium phosphate, lactic acid, phosphoric acid concentrated, potassium sorbate, citric acid monohydrate.
30 ml - vials of dark glass (1) with a stopper-dropper and a plastic cover with the control of the first opening - packs cardboard.
100 ml - vials of dark glass (1) with a stopper-dropper and a plastic cover with the control of the first opening - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2013.
PHARMACHOLOGIC EFFECT
The natural physiological microflora of the intestine can be significantly disturbed by such external influences as antibiotic therapy, irradiation, stomach surgery, as well as due to unsuitable and unusual food, water changes, climate change and other conditions.
Hilak forte regulates the balance of the intestinal microflora and normalizes its composition. Thanks to the content of normal metabolic products in the product, Hilak forte helps restore the normal intestinal microflora in a biological way and allows preserving the physiological and biological functions of the intestinal mucosa.
The biosynthetic lactic acid and its buffer salts included in the preparation restore the normal value of acidity in the digestive tract, regardless of whether the patient has an increased or decreased acidity.
Against the background of the acceleration of the development of normal intestinal symbionts under the influence of the Hilak forte preparation, the natural synthesis of B and K group vitamins normalizes. The short-chain volatile fatty acids contained in the preparation provide restoration of the damaged intestinal microflora in infectious diseases of the gastrointestinal tract, stimulate regeneration of the epithelial cells of the intestinal wall, restore the disturbed water-electrolyte balance in the gut lumen.
There is evidence that Hilak forte enhances the protective functions of the body by stimulating the immune response.
With the application of Hilak forte, there is an acceleration in the excretion of salmonella in infants after salmonella enteritis, which is due to the stimulation of the growth of the acidophilic anaerobic flora and its subsequent antagonistic action on salmonella.
INDICATIONS
- violations of the physiological flora of the intestine (during and after treatment with antibiotics, sulfonamides, radiation therapy);
- a syndrome of insufficiency of digestion, a dyspepsia;
- Diarrhea, flatulence, constipation;
- gastroenteritis, colitis;
- Syndrome of the elderly intestine (chronic, atrophic gastroenteritis);
- GI disorders due to climate change;
- hypo- and anadic states;
- Enterogenic diseases of the gallbladder and liver;
- allergic skin diseases (urticaria, endogenously caused chronic eczema);
- salmonellosis in the stage of convalescence (including in infants).
DOSING MODE
For adults, the drug is prescribed 40-60 drops 3 times / day; children - 20-40 drops 3 times / day; Infants - 15-30 drops 3 times / day. After the improvement, the initial daily dose of Hilak forte can be reduced by half.
The drug is taken by mouth before or during meals, diluting in a small amount of liquid, excluding milk.
SIDE EFFECT
Adverse reactions have not been observed to date.
From the digestive system: possible constipation, diarrhea.
Allergic reactions: skin rash, itching, hives are possible.
Hilak forte is well tolerated by patients of any age.
CONTRAINDICATIONS
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
The use of Hilak forte during pregnancy and lactation (breastfeeding) is considered safe. The decision to prescribe the drug is taken by a doctor.
APPLICATION FOR CHILDREN
For children, the drug is prescribed 20-40 drops 3 times / day; Infants - 15-30 drops 3 times / day. After the improvement, the initial daily dose of Hilak forte can be reduced by half.
SPECIAL INSTRUCTIONS
It is not recommended to take the drug simultaneously with milk and dairy products.
OVERDOSE
No special measures, with the exception of routine medical supervision, are required.
DRUG INTERACTION
When used simultaneously with antacids, it is possible to neutralize lactic acid, which is part of the drug Hilak forte.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of the reach of children at a temperature of no higher than 25 В° C. Shelf life - 4 years, after opening the bottle - 6 weeks.
